EMN
50
-2
GLW
48
-5
FLS
76
-2
HSY
43
3
C
62
-3
LEN
52
2
LNC
45
-4
ADI
45
-5
TROW
51
-2
OXY
55
6
STZ
58
3
SLG
62
-4
PLD
56
8
DRI
56
2
NTAP
61
-3
BMY
61
-3
MA
67
-5
CSX
68
3
LB
63
-4
EMC
53
-3
EMN
50
-2
GLW
48
-5
FLS
76
-2
HSY
43
3
C
62
-3
LEN
52
2
LNC
45
-4
ADI
45
-5
TROW
51
-2
OXY
55
6
STZ
58
3
SLG
62
-4
PLD
56
8
DRI
56
2
NTAP
61
-3
BMY
61
-3
MA
67
-5
CSX
68
3
LB
63
-4
EMC
53
-3
Financhill
Back

Regeneron Pharmaceuticals Vs. AbbVie Industry Stock Comparison

Sell
42

REGN
Regeneron Pharmaceuticals

Last Price:
781.46
Seasonality Move:
14.2%
Sell
31

ABBV
AbbVie

Last Price:
169.64
Seasonality Move:
4.77%
Sell
42
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $804.33. The Score for REGN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
AbbVie (ABBV) is a Sell

Is AbbVie a Buy, Sell or Hold?

  • The current AbbVie [ABBV] share price is $170.35. The Score for ABBV is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • ABBV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $804.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.

ABBV Stock Price Chart

What is AbbVie's stock price today?

  • The AbbVie share price today is $170.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABBV is experiencing selling pressure, which indicates risk of future bearish movement.

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -56.85 Sell
Relative Strength Index (14 RSI): 15.94 Sell
Chaikin Money Flow: -529793 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (836.26 - 990.14) Sell
Bollinger Bands (100): (951.78 - 1157.76) Sell

ABBV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.23 Sell
Relative Strength Index (14 RSI): 25.54 Sell
Chaikin Money Flow: -4446578 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (182.77 - 201.07) Sell
Bollinger Bands (100): (176.81 - 198.55) Sell

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 822.36 Sell
20-day SMA: 888.61 Sell
50-day SMA: 1003.71 Sell
200-day SMA: 1008.1 Sell
8-day EMA: 830.33 Sell
20-day EMA: 881.51 Sell
50-day EMA: 965.43 Sell
200-day EMA: 989.48 Sell

ABBV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 189.9 Sell
20-day SMA: 191.36 Sell
50-day SMA: 193.24 Sell
200-day SMA: 178.8 Sell
8-day EMA: 184.7 Sell
20-day EMA: 190.24 Sell
50-day EMA: 191.21 Sell
200-day EMA: 179.26 Sell

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.45 per share, and an increase next year of $0.51 per share.

AbbVie Earnings Growth & ABBV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $1.17 per share.

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

AbbVie Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):